LPCN
Lipocine Inc
NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY
$2.33
+0.00% today
Updated 2026-05-01
Market cap
$19.02M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.77
Dividend yield
—
52W range
$2 – $12
Volume
0.5M
Lipocine Inc (LPCN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.09M | $7.71M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $428031.00 | $164990.00 | $0.00 | $16.14M | $500000.00 | $-2.85M | $11.20M | $1.98M |
| Revenue growth (YoY) | — | +149.6% | -100.0% | — | — | — | — | — | -61.5% | -100.0% | — | -96.9% | -670.2% | +492.8% | -82.3% |
| Cost of revenue | $5.38M | $3.79M | $5.12M | $15.48M | $12.58M | $8.08M | $11.00M | $6.46M | $7.47M | $9.75M | $7.67M | $8.56M | $10.18M | $41106.00 | $8.58M |
| Gross profit | — | $3.92M | $-5.12M | $-15.48M | $-12.58M | $-8.08M | $-11.00M | $428031.00 | $-7.30M | $-9.75M | $8.48M | $-8.06M | $-13.03M | $11.20M | $-6.61M |
| Gross margin | 0.0% | 50.9% | — | — | — | — | — | 100.0% | -4426.5% | — | 52.5% | -1611.4% | 456.9% | 100.0% | -334.3% |
| R&D | $3.11M | $2.28M | $5.59M | $15.48M | $12.58M | $8.08M | $11.00M | $6.46M | $7.47M | $9.75M | $7.67M | $8.56M | $10.18M | $7.35M | $8.58M |
| SG&A | $4996.00 | $75725.00 | $3.64M | $5.00M | $5.80M | $10.38M | $10.21M | $5.29M | $5.60M | $8.25M | $5.33M | $4.06M | $4.90M | $5.00M | $3.76M |
| Operating income | $-5162.00 | $-76654.00 | $-8.76M | $-20.48M | $-18.38M | $-18.46M | $-21.22M | $-11.33M | $-12.90M | $-18.00M | $3.15M | $-12.12M | $-17.93M | $-1.16M | $-10.37M |
| Operating margin | -0.2% | -1.0% | — | — | — | — | — | -2646.0% | -7818.8% | — | 19.5% | -2423.9% | 629.0% | -10.3% | -524.7% |
| EBITDA | $-5162.00 | $-76654.00 | $-10.62M | $-20.47M | $-18.36M | $-18.94M | $-21.19M | $-11.31M | $-12.22M | $-17.99M | $-430527.00 | $-10.72M | $-17.90M | $-1.11M | $-10.31M |
| EBITDA margin | -0.2% | -1.0% | — | — | — | — | — | -2641.7% | -7409.5% | — | -2.7% | -2144.3% | 628.0% | -9.9% | -521.6% |
| EBIT | $-5162.00 | $-76654.00 | $-10.65M | $-20.48M | $-18.38M | $-18.97M | $-21.22M | $-11.33M | $-12.24M | $-18.00M | $-430907.00 | $-10.73M | $-17.93M | $-1.16M | $-10.37M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $343254.00 | $386618.00 | $203292.00 | $27098.00 | $0.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-5162.00 | $-76654.00 | $-10.59M | $-20.37M | $-18.21M | $-18.97M | $-20.98M | $-11.66M | $-13.01M | $-20.96M | $-634399.00 | $-10.76M | $-16.35M | $8352.00 | $-9.63M |
| Net income growth (YoY) | — | -1385.0% | -13715.5% | -92.4% | +10.6% | -4.2% | -10.6% | +44.4% | -11.6% | -61.2% | +97.0% | -1595.9% | -52.0% | +100.1% | -115371.9% |
| Profit margin | -0.2% | -1.0% | — | — | — | — | — | -2724.1% | -7883.7% | — | -3.9% | -2151.7% | 573.6% | 0.1% | -487.1% |